Health and Fitness Health and Fitness
Thu, March 7, 2013
Wed, March 6, 2013
[ Wed, Mar 06th 2013 ] - Market Wire
Alchemia Granted Key US Patent
Tue, March 5, 2013
Mon, March 4, 2013
Sun, March 3, 2013
Sat, March 2, 2013
Fri, March 1, 2013
Thu, February 28, 2013
Wed, February 27, 2013
Tue, February 26, 2013
Mon, February 25, 2013
Sun, February 24, 2013
Sat, February 23, 2013
Fri, February 22, 2013
Thu, February 21, 2013
[ Thu, Feb 21st 2013 ] - Market Wire
Inorganic Growth of Healthcare
Wed, February 20, 2013
Tue, February 19, 2013
Mon, February 18, 2013
Sun, February 17, 2013
Fri, February 15, 2013
Thu, February 14, 2013
Wed, February 13, 2013

Horizon Pharma to Present at the Cowen and Company 33rd Annual Health Care Conference


//health-fitness.news-articles.net/content/2013/ .. -company-33rd-annual-health-care-conference.html
Published in Health and Fitness on Tuesday, February 26th 2013 at 4:45 GMT by Market Wire   Print publication without navigation


February 26, 2013 07:30 ET

Horizon Pharma to Present at the Cowen and Company 33rd Annual Health Care Conference

DEERFIELD, IL--(Marketwire - Feb 26, 2013) -  Horizon Pharma, Inc. (NASDAQ: [ HZNP ]), today announced that Timothy P. Walbert, chairman, president and chief executive officer will present at the Cowen and Company 33rd Annual Health Care Conference on Tuesday, March 5th at 10:00a.m. Eastern Time in Boston, MA. Mr. Walbert will provide an overview of the Company and its corporate activities.

The presentation will be webcast live and may be accessed by visiting Horizon's website at [ http://ir.horizon-pharma.com ]. A replay of the webcast will be available for 10 business days.

About Horizon Pharma
Horizon Pharma, Inc. is a specialty pharmaceutical company that has developed and is commercializing DUEXIS and RAYOS/LODOTRA, both of which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The Company's strategy is to develop, acquire, in-license and/or co-promote additional innovative medicines where it can execute a targeted commercial approach in specific therapeutic areas while taking advantage of its commercial strengths and the infrastructure the Company has put in place. For more information, please visit [ www.horizonpharma.com ].



Publication Contributing Sources